AR045284A1 - USE OF AN INHIBITOR COMPOUND FOR SEROTONINE RECOVERY AND AN INHIBITOR COMPOUND OF THE TYPE I GLICINE CARRIER FOR DEPRESSION TREATMENT - Google Patents
USE OF AN INHIBITOR COMPOUND FOR SEROTONINE RECOVERY AND AN INHIBITOR COMPOUND OF THE TYPE I GLICINE CARRIER FOR DEPRESSION TREATMENTInfo
- Publication number
- AR045284A1 AR045284A1 ARP040102976A ARP040102976A AR045284A1 AR 045284 A1 AR045284 A1 AR 045284A1 AR P040102976 A ARP040102976 A AR P040102976A AR P040102976 A ARP040102976 A AR P040102976A AR 045284 A1 AR045284 A1 AR 045284A1
- Authority
- AR
- Argentina
- Prior art keywords
- disorders
- disorder
- inhibitor compound
- anxiety
- inhibitor
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Uso de compuesto, que es un inhibidor de la recaptación de serotonina, y un compuesto, que es un inhibidor del transportador de Glicina tipo 1 (GlyT-1), para la preparación de una composición farmacéutica para el tratamiento de depresión, trastornos de ansiedad y otros trastornos afectivos. En particular se refiere al tratamiento de depresión, trastornos de ansiedad y otros trastornos afectivos, tales como trastorno de ansiedad generalizada, ansiedad de pánico, trastorno compulsivo obsesivo, trastorno de estrés agudo, trastorno de estrés post-traumático y trastorno de ansiedad social, trastornos de la alimentación tales como bulimia, anorexia y obesidad, fobias, distimia, síndrome premenstrual, trastornos cognoscitivos, trastornos de control del impulsivo, trastorno de hiperactividad de déficit de atención, abuso de drogas o cualquier otro trastorno que responda a inhibidores de la recaptación de serotonina. Composición farmacéutica que comprende un inhibidor de la recaptación de serotonina y un inhibidor de Gly-T-1.Use of compound, which is a serotonin reuptake inhibitor, and a compound, which is an inhibitor of glycine transporter type 1 (GlyT-1), for the preparation of a pharmaceutical composition for the treatment of depression, anxiety disorders and other affective disorders. In particular it refers to the treatment of depression, anxiety disorders and other affective disorders, such as generalized anxiety disorder, panic anxiety, obsessive compulsive disorder, acute stress disorder, post-traumatic stress disorder and social anxiety disorder, disorders of eating such as bulimia, anorexia and obesity, phobias, dysthymia, premenstrual syndrome, cognitive disorders, impulse control disorders, attention deficit hyperactivity disorder, drug abuse or any other disorder that responds to reuptake inhibitors of serotonin Pharmaceutical composition comprising a serotonin reuptake inhibitor and a Gly-T-1 inhibitor.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301198 | 2003-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR045284A1 true AR045284A1 (en) | 2005-10-19 |
Family
ID=58707234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040102976A AR045284A1 (en) | 2003-08-21 | 2004-08-19 | USE OF AN INHIBITOR COMPOUND FOR SEROTONINE RECOVERY AND AN INHIBITOR COMPOUND OF THE TYPE I GLICINE CARRIER FOR DEPRESSION TREATMENT |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR045284A1 (en) |
| CO (1) | CO5680458A2 (en) |
| EA (1) | EA200600453A1 (en) |
| IL (1) | IL173825A0 (en) |
| ZA (1) | ZA200601084B (en) |
-
2004
- 2004-08-18 ZA ZA200601084A patent/ZA200601084B/en unknown
- 2004-08-18 EA EA200600453A patent/EA200600453A1/en unknown
- 2004-08-19 AR ARP040102976A patent/AR045284A1/en not_active Application Discontinuation
-
2006
- 2006-02-17 CO CO06016118A patent/CO5680458A2/en not_active Application Discontinuation
- 2006-02-20 IL IL173825A patent/IL173825A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL173825A0 (en) | 2006-07-05 |
| ZA200601084B (en) | 2007-04-25 |
| CO5680458A2 (en) | 2006-09-29 |
| EA200600453A1 (en) | 2006-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124111T1 (en) | GLUTAMATE REGULATORS IN THE TREATMENT OF MENTAL DISORDERS | |
| ME00039B (en) | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | |
| UY29079A1 (en) | PHENOXYACETIC ACIDS REPLACED, COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS | |
| UY28482A1 (en) | NEW COMPOUNDS | |
| DK1238676T3 (en) | Combination of a serotonin reuptake inhibitor and an atypical antipsychotic for use in depression, obsessive-compulsive disorder and psychosis | |
| NO20060242L (en) | The combination of a serotonin reuptake inhibitor and agomelatine | |
| CO6640335A2 (en) | Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity or prediabetes | |
| BR0314277A (en) | Compound; method of treatment of an individual with depression, anxiety, panic disorder, post-traumatic tension, premenstrual dysphoric, attention deficit, obsessive-compulsive and eating disorders, obesity, vasomotor flushing, alcohol dependence and cocaine and sexual dysfunction; pharmaceutical composition and use thereof | |
| CL2008002247A1 (en) | Compounds derived from phenyl amide; Preparation process; pharmaceutical composition containing them; and its use in the preparation of drugs for the treatment of sleep disorders, narcolepsy and psychiatric disorders, among others. | |
| DE602007014206D1 (en) | Novel serotonin reuptake inhibitor as a drug with peripheric system-restricted activity | |
| ATE459353T1 (en) | GABOXADOL USED TO TREAT DEPRESSION AND OTHER AFFECTIVE DISORDERS | |
| DK1626720T3 (en) | 4- (2-Phenylsulfanyl-phenyl) -piperidine derivatives as serotonin reuptake inhibitors | |
| NO20061167L (en) | The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression | |
| PE20040924A1 (en) | ESCITALOPRAM BROMHYDRATE AND A METHOD FOR ITS PREPARATION | |
| DK1545552T3 (en) | Combination therapy using a serotin reuptake inhibitor | |
| AR045284A1 (en) | USE OF AN INHIBITOR COMPOUND FOR SEROTONINE RECOVERY AND AN INHIBITOR COMPOUND OF THE TYPE I GLICINE CARRIER FOR DEPRESSION TREATMENT | |
| AR047715A1 (en) | ANALEPTIC AND ANTDEPRESSIVE COMBINATIONS | |
| EA200801080A1 (en) | STABLE PHARMACEUTICAL MEDICINE FORMS CONTAINING ESCITALOPRAM AND BUPROPION | |
| MX2011012596A (en) | Methods of enhancing selective serotonin reuptake inhibitor effects in mammals. | |
| AR048134A1 (en) | THE COMBINATION OF AN INHIBITOR OF THE RECOVERY OF SEROTONINE AND AN ANTAGONIST OF THE RECEIVER OF HISTAMINE 3, THE INVESTED AGONIST OR THE PARTIAL AGONIST | |
| AR045314A1 (en) | PHARMACEUTICAL COMPOSITIONS OF ANALEPTICS AND ANTIDEPRESSANTS | |
| DE60315843D1 (en) | ANTIDEPRESSIVE INDOLALKYL DERIVATIVES OF HETEROCYCLIC-CONDENSED BENZODIOXANETHYLAMINES | |
| BR0314431A (en) | Antidepressant piperidine derivatives of heterocyl-fused benzodioxanes | |
| CO5680440A2 (en) | COMBINATION THERAPY WHERE A SEROTONINE RECOVERY INHIBITOR IS USED | |
| WO2005056056A3 (en) | The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |